Table 1 Characteristics of the studied participants

From: Reference values of office central blood pressure, pulse wave velocity, and augmentation index recorded by means of the Mobil‐O‐Graph PWA monitor

Variables

CVRF-No

CVRF-Yes

Women (n = 531)

Men (n = 336)

Women (n = 3169)

Men (n = 2463)

Age, years

47.1 ± 14.7

44.1 ± 16.5*

58.6 ± 14.1

54.8 ± 15.1*

Weight, kg

63.5 ± 9.5

76.6 ± 11.0*

71.4 ± 14.7

85.9 ± 17.4*

Height, m

1.60 ± 0.07

1.73 ± 0.08*

1.58 ± 0.07

1.71 ± 0.08*

Body mass index, kg/m2

24.7 ± 3.1

25.6 ± 2.8*

28.6 ± 5.3

29.2 ± 5.0*

Obesity, %

36

40*

Diabetes mellitus, %

24

25

Current smoking, %

2

5*

Dyslipidemia, %

47

41*

Physical activity, %

29

35

23

26

Alcohol use, %

10

22*

6

18*

Hypertension, %

83

84

Antihypertensive med, %

61

56*

Peripheral BP categories, %

    

 Optimal

49

28*

17

15

 Normal

27

36*

19

17

 High normal

24

36*

19

20

 Stage 1 hypertension

30

33

 Stage 2 hypertension

11

11

 Stage 3 hypertension

4

4

Heart rate, b.p.m.

73.1 ± 11.2

71.4 ± 11.4

72.7 ± 12.2

71.9 ± 13.0

Peripheral SBP, mmHg

117.3 ± 10.7

122.2 ± 9.6*

134.8 ± 19.1

132.8 ± 16.9*

Peripheral DBP, mmHg

74.8 ± 8.4

77.1 ± 7.8*

82.0 ± 12.4

85.5 ± 12.2*

Peripheral PP, mmHg

42.5 ± 9.0

45.1 ± 10.1*

52.8 ± 15.3

47.3 ± 13.1*

Peripheral MAP, mmHg

89.0 ± 8.2

92.1 ± 7.0*

99.6 ± 13.1

101.3 ± 12.5*

Central SBP, mmHg

110.1 ± 11.2

113.9 ± 10.8*

127.4 ± 19.6

124.9 ± 17.0*

Central DBP, mmHg

76.0 ± 8.5

78.8 ± 7.7*

83.3 ± 12.5

86.9 ± 12.3*

Central PP, mmHg

34.1 ± 9.4

35.1 ± 10.3

44.1 ± 15.7

38.0 ± 12.7*

Pulse wave velocity, m/s

6.9 ± 1.8

6.9 ± 1.8

8.8 ± 2.2

8.3 ± 2.0*

Augmentation index

23.0 ± 10.9

15.0 ± 10.9*

27.3 ± 12.4

17.5 ± 11.8*

  1. BP blood pressure, SBP systolic blood pressure, DBP diastolic blood pressure, PP pulse pressure, MAP mean arterial pressure, CVRF cardiovascular risk factors, med medications
  2. *p < 0.05 compared with women within the same group
  3. p < 0.05 compared with CVRF-No of the same sex